INS and obesity due to melanocortin 4 receptor deficiency: Insulin levels decreased significantly (p < 0.001) from 114.4 ± 63.5 pmol/L to 92.4 ± 53.1 pmol/L following treatment, suggesting that obesity‐related high insulin levels can be improved following walking therapy.